Basics Gossamer Bio, Inc. IPO Date: February 4, 2019 Sector: Healthcare Industry: Biotech Market Cap: $329.59M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.55% Avg Daily Range (30 D): $0.05 | 3.27% Avg Daily Range (90 D): $0.05 | 4.18% Institutional Daily Volume Avg Daily Volume: 1.09M Avg Daily Volume (30 D): 1.87M Avg Daily Volume (90 D): 1.58M Trade Size Avg Trade Size (Sh.): 172 Avg Trade Size (Sh.) (30 D): 231 Avg Trade Size (Sh.) (90 D): 222 Institutional Trades Total Inst.Trades: 1,269 Avg Inst. Trade: $1.46M Avg Inst. Trade (30 D): $5.27M Avg Inst. Trade (90 D): $5.27M Avg Inst. Trade Volume: .26M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.73M Avg Closing Trade (30 D): $19.93M Avg Closing Trade (90 D): $19.93M Avg Closing Volume: 328.17K     News Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Dec 2, 2024 @ 12:30 PM XOMA Royalty Acquires Pulmokine for $20 Million Ad... Source: Globe Newswire Jun 25, 2024 @ 6:39 PM Gossamer Bio's Clean Safety Profile Differentiates... Source: Vandana Singh May 19, 2024 @ 10:35 AM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast Mar 7, 2024 @ 2:55 PM Should You Buy Gossamer Bio (GOSS) After Golden Cr... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.23 $-.16 $-.15 Diluted EPS $-.23 $-.16 $-.15 Revenue $ 124.59M $ 9.89M $ 9.38M Gross Profit $ $ $ Net Income / Loss $ -51.24M $ -36.64M $ -33.03M Operating Income / Loss $ -54.77M $ -36.81M $ -36.13M Cost of Revenue $ $ $ Net Cash Flow $ -9.91M $ -17.16M $ 17.74M PE Ratio